Journal of Cancer Research and Clinical Oncology

Journal of Cancer Research and Clinical Oncology OnlineFirst articles

02.12.2020 | Original Article – Cancer Research Open Access

Treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer initiating first-line treatment in the US community oncology setting: a real-world retrospective observational study

The treatment landscape for advanced, unresectable, and/or metastatic non-small cell lung cancer (NSCLC) is evolving. Although doublet and triplet systemic chemotherapies were the mainstay treatment of advanced NSCLC for decades, limited …

PDF-Version jetzt herunterladen Zum Volltext

26.11.2020 | Original Article – Clinical Oncology Open Access

Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in women (Bray et al. 2018 ), with metastatic disease accounting for the majority of deaths (Dillekas et al. 2019 ). In most women treated with …

PDF-Version jetzt herunterladen Zum Volltext

25.11.2020 | Original Article – Cancer Research Open Access

Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal type of human cancer, with a low 5-year survival rate of 6–10% (Yao et al. 2020 ). Recently, although programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) blocking …

PDF-Version jetzt herunterladen Zum Volltext

24.11.2020 | Review – Clinical Oncology Open Access

Risk of lung cancer and renin–angiotensin blockade: a concise review

The blockade of the renin–angiotensin–aldosterone system (RAAS) has immensely improved the treatment of patients with chronic arterial hypertension, acute myocardial infarction, chronic systolic heart failure, stroke, diabetic nephropathy and …

PDF-Version jetzt herunterladen Zum Volltext

24.11.2020 | Original Article – Cancer Research Open Access

Mitochondrial DNA analysis efficiently contributes to the identification of metastatic contralateral breast cancers

Patients who experienced a breast neoplasia have a higher risk of developing a contralateral breast cancer (CBC) during their lifetime (Chen et al. 1999 ; Peralta et al. 2000 ; Goldstein et al. 2003 ; Raymond and Hogue 2006 ; Hartman et al. 2007 ).

PDF-Version jetzt herunterladen Zum Volltext

Weitere Informationen

Titel

Journal of Cancer Research and Clinical Oncology

Verlag

Springer Berlin Heidelberg

Abdeckung

Volume 123/1997 - Volume 146/2020

Print ISSN

0171-5216

Elektronische ISSN

1432-1335

DOI

https://doi.org/10.1007/432.1432-1335

Zeitschriften-ID

432